{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:58:35Z","timestamp":1789383515712,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurologic.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ncl.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T13:12:39Z","timestamp":1491916359000},"page":"325-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Lewy Body Disorders"],"prefix":"10.1016","volume":"35","author":[{"given":"Douglas","family":"Galasko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2017.01.004_bib1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB)","volume":"67","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2017.01.004_bib2","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2017.01.004_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/0891988704267470","article-title":"Are Parkinson\u2019s disease with dementia and dementia with Lewy bodies the same entity?","volume":"17","author":"Aarsland","year":"2004","journal-title":"J\u00a0Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.ncl.2017.01.004_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","article-title":"Pathological \u03b1-synuclein distribution in subjects with coincident Alzheimer\u2019s and Lewy body pathology","volume":"131","author":"Toledo","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ncl.2017.01.004_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ncl.2017.01.004_bib6","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","article-title":"Lewy body dementias","volume":"386","author":"Walker","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2017.01.004_bib7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jnen\/nlv028","article-title":"Neuropathology of autosomal dominant Alzheimer disease in the National Alzheimer Coordinating Center database","volume":"75","author":"Ringman","year":"2016","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.ncl.2017.01.004_bib8","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2017.01.004_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","article-title":"The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies","volume":"44","author":"Vann Jones","year":"2014","journal-title":"Psychol Med"},{"key":"10.1016\/j.ncl.2017.01.004_bib10","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1212\/WNL.0b013e3182a2cbd1","article-title":"Risk factors for dementia with Lewy bodies: a case-control study","volume":"81","author":"Boot","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2017.01.004_bib11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2017.01.004_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study","volume":"60","author":"Aarsland","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2017.01.004_bib13","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/brain\/awv104","article-title":"Parkinson\u2019s disease dementia: a neural networks perspective","volume":"138","author":"Gratwicke","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2017.01.004_bib14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson\u2019s disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.ncl.2017.01.004_bib15","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","article-title":"Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies","volume":"23","author":"Bras","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ncl.2017.01.004_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","article-title":"APOE epsilon4 increases risk for dementia in pure synucleinopathies","volume":"70","author":"Tsuang","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2017.01.004_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1474-4422(03)00351-X","article-title":"Dementia associated with Parkinson's disease","volume":"2","author":"Emre","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2017.01.004_bib18","first-page":"229","article-title":"Systemic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia","volume":"16","author":"Collerton","year":"2003","journal-title":"Dementia"},{"key":"10.1016\/j.ncl.2017.01.004_bib19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1192\/bjp.177.3.252","article-title":"The clinician assessment of fluctuation and the one day fluctuation assessment scale. Two methods to assess fluctuating confusion in dementia","volume":"177","author":"Walker","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.ncl.2017.01.004_bib20","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1212\/WNL.62.2.181","article-title":"DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging","volume":"62","author":"Ferman","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2017.01.004_bib21","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/mds.23525","article-title":"Cognitive correlates of visual hallucinations in dementia associated with Parkinson\u2019s disease","volume":"26","author":"Bronnick","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2017.01.004_bib22","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/brain\/aww175","article-title":"Visual dysfunction in Parkinson's disease","volume":"139","author":"Weil","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2017.01.004_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jnnp.2005.081711","article-title":"Motor subtype and cognitive decline in Parkinson\u2019s disease, Parkinson\u2019s disease with dementia, and dementia with Lewy bodies","volume":"77","author":"Burn","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2017.01.004_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000375363","article-title":"Clinical and neuropsychological differences between mild Parkinson's disease dementia and dementia with Lewy bodies","volume":"5","author":"Petrova","year":"2015","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.1016\/j.ncl.2017.01.004_bib25","first-page":"1731","article-title":"Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies","volume":"260","author":"Onofrj","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2017.01.004_bib26","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.2004.052332","article-title":"The role of levodopa in the management of dementia with Lewy bodies","volume":"76","author":"Molloy","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2017.01.004_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/0891988704267465","article-title":"REM sleep behavior disorder in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"17","author":"Boeve","year":"2004","journal-title":"J\u00a0Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.ncl.2017.01.004_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: movement disorder society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2017.01.004_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1017\/S0033291714000816","article-title":"Prodromal dementia with Lewy bodies","volume":"45","author":"Donaghy","year":"2015","journal-title":"Psychol Med"},{"key":"10.1016\/j.ncl.2017.01.004_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1212\/WNL.51.2.363","article-title":"REM sleep behavior disorder and degenerative dementia. An association likely reflecting Lewy body disease","volume":"51","author":"Boeve","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2017.01.004_bib31","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archneur.61.6.919","article-title":"Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies","volume":"61","author":"O'Brien","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2017.01.004_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","article-title":"Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study","volume":"6","author":"McKeith","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2017.01.004_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF02984560","article-title":"Significance of I-123-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson\u2019s disease and related disorders: it can be a specific marker for Lewy body disease","volume":"18","author":"Taki","year":"2004","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.ncl.2017.01.004_bib34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ana.24717","article-title":"I-2\u03b2-carbomethoxy-3\u03b2-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with Lewy bodies from other dementias: a comparative study","volume":"80","author":"Tiraboschi","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2017.01.004_bib35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.1133","article-title":"Alzheimer\u2019s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation","volume":"50","author":"Minoshima","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2017.01.004_bib36","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1212\/WNL.0000000000000734","article-title":"Dementia with Lewy bodies: basis of cingulate island sign","volume":"83","author":"Graff-Radford","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2017.01.004_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.nicl.2016.02.019","article-title":"Differential diagnosis of neurodegenerative diseases using structural MRI data","volume":"11","author":"Koikkalainen","year":"2016","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.ncl.2017.01.004_bib38","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neurobiolaging.2014.07.005","article-title":"Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies","volume":"36","author":"Nedelska","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ncl.2017.01.004_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/mds.25352","article-title":"Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease?","volume":"28","author":"Duncan","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2017.01.004_bib40","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/mds.25048","article-title":"Brain amyloid and cognition in Lewy body diseases","volume":"27","author":"Gomperts","year":"2012","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.ncl.2017.01.004_bib41","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","article-title":"Tau positron emission tomographic imaging in the Lewy body diseases","volume":"73","author":"Gomperts","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2017.01.004_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.clinph.2015.06.020","article-title":"Neurophysiological biomarkers for Lewy body dementias","volume":"127","author":"Cromarty","year":"2016","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.ncl.2017.01.004_bib43","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1515\/CCLM.2006.258","article-title":"Analytical performance and clinical utility of the INNOTESTVR PHOSPHO-TAU (181P) assay for discrimination between Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"44","author":"Vanderstichele","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ncl.2017.01.004_bib44","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/mds.26668","article-title":"Alzheimer\u2019s disease cerebrospinal fluid biomarkers predict cognitive decline in Lewy body dementia","volume":"31","author":"Abdelnour","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2017.01.004_bib45","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/mds.26662","article-title":"Biomarkers for dementia and mild cognitive impairment in Parkinson's disease","volume":"31","author":"Delgado-Alvarado","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2017.01.004_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/alzrt255","article-title":"Levels of cerebrospinal fluid \u03b1-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease","volume":"6","author":"Hansson","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.ncl.2017.01.004_bib47","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1176\/appi.ajp.2015.14121582","article-title":"Pharmacological management of Lewy body dementias: a systematic review and meta-analysis","volume":"172","author":"Stinton","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ncl.2017.01.004_bib48","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomized, double-blind, placebo-controlled international study","volume":"356","author":"McKeith","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2017.01.004_bib49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-014-0081-2","article-title":"Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of phase III trial","volume":"7","author":"Mori","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.ncl.2017.01.004_bib50","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease","volume":"351","author":"Emre","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2017.01.004_bib51","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jagp.2013.11.007","article-title":"Memantine for Lewy body disorders: systematic review and meta-analysis","volume":"23","author":"Matsunaga","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.ncl.2017.01.004_bib52","doi-asserted-by":"crossref","first-page":"e005158","DOI":"10.1136\/bmjopen-2014-005158","article-title":"Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson\u2019s disease with dementia: a prospective study","volume":"4","author":"Stubendorff","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.ncl.2017.01.004_bib53","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/01.wnl.0000215428.46057.3d","article-title":"Practice parameter: evaluation and treatment of depression, psychosis and dementia in Parkinson's disease (an evidenced-based review)","volume":"66","author":"Miyasaki","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2017.01.004_bib54","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.parkreldis.2015.04.018","article-title":"Antidepressive treatments for Parkinson's disease: a systematic review and meta-analysis","volume":"21","author":"Bomasang-Layno","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2017.01.004_bib55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"issue":"9916","key":"10.1016\/j.ncl.2017.01.004_bib56","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(13)62106-6","article-title":"Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial","volume":"383","author":"Cummings","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2017.01.004_bib57","unstructured":"Revisions proposed at the 4th International DLB Symposium. Lauderdale (FL), December 1-4, 2015."}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386191730004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386191730004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T20:27:07Z","timestamp":1535920027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386191730004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S073386191730004X"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2017.01.004","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lewy Body Disorders","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2017.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}